Dr. Carris joins National Academies committee advising on opioid prescribing guidelines

USF Health’s Nicholas Carris, PharmD, has been appointed to a National Academies of Sciences, Engineering, and Medicine ad hoc committee that will help shape evidence-based clinical practice guidelines for prescribing opioids to treat acute pain.

Dr. Carris is an assistant professor in the College of Pharmacy’s Department of Pharmacotherapeutics and Clinical Research and holds a joint appointment in the USF Health Morsani College of Medicine’s Department of Family Medicine.

The 14-member National Academies ad hoc committee Dr. Carris serves on is carrying out a study sponsored by the Food and Drug Administration (FDA).  It has been charged with recommending a framework to generate easily accessible, evidence-based clinical practice guidelines for effectively managing with opioid drugs the acute pain associated with specific medical procedures and conditions. Committee members, appointed in November 2018, will serve for 16 months and their recommendations will be used by the FDA in publicly available materials.

A board certified pharmacotherapy specialist, Dr. Carris has significant training and expertise in drug therapy.  He currently collaborates with a regional accountable care organization to implement the federal Centers for Disease Control and Prevention’s opioid use guidelines, including working with key stakeholders and physicians to emphasize deprescribing.

Dr. Carris is a member of the American College of Cardiology, the American College of Clinical Pharmacy (ACCP), and the ACCP Ambulatory Care Practice and Research Network (Ambulatory Care PRN), which connects members from a diverse array of outpatient settings focusing on chronic disease management.